In our last Letter from the Editor, we incorrectly reported the name of Schering's Primovist MRI contrast agent in our story about European Union approval of the product.
Correction
Oct 4, 2004
Latest in Clinical News
Image-based grading system estimates nasopharyngeal carcinoma severity
September 23, 2026
ASTRO 2026 to center on translating radiotherapy data into dialogue
September 23, 2026
Podcast: OSHA report reveals more about 2023 MRI accident
September 22, 2026


















